Drug Trial Radar · NCT02612311
Ublituximab + TGR-1202 Compared to Obinutuzumab + Chlorambucil in Participants With Untreated and Previously Treated Chronic Lymphocytic Leukemia
Last checked: Nov 19, 2026Latest source record: Dec 13, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
603
Actual
Start
Nov 19, 2015
Primary completion
Feb 22, 2023
Study completion Feb 22, 2023
Sponsor
- Lead sponsor
- TG Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Nov 23, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study evaluates the combination of ublituximab, a novel monoclonal antibody, and TGR-1202, a novel PI3K delta inhibitor compared to obinutuzumab and chlorambucil, and compared to ublituximab or TGR-1202 alone in Chronic Lymphocytic Leukemia (CLL) participants.
Conditions
- Chronic Lymphocytic Leukemia
Interventions
ObinutuzumabBiological
Obinutuzumab: IV infusion
UblituximabBiological
Ublituximab: IV infusion
TGR-1202Drug
TGR-1202: Oral daily dose
ChlorambucilDrug
Chlorambucil: Oral dose
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression-Free Survival (PFS) Per International Workshop on Chronic Lymphocytic Leukemia (iwCLL) CriteriaTime frame: From enrolment to the earlier of the first documentation of definitive disease progression (PD) or death (Up to 87 months)
Locations
154 sites in 7 countries. Site status is shown where the registry gives one.
TG Therapeutics Investigational Trial Site
Huntsville, Alabama
TG Therapeutics Investigational Trial Site
Mobile, Alabama
TG Therapeutics Investigational Trial Site
Chandler, Arizona
TG Therapeutics Investigational Trial Site
Phoenix, Arizona
TG Therapeutics Investigational Trial Site
Tucson, Arizona
TG Therapeutics Investigational Trial Site
Fayetteville, Arkansas
TG Therapeutics Investigational Trial Site
Concord, California
TG Therapeutics Investigational Trial Site
Duarte, California
TG Therapeutics Investigational Trial Site
Greenbrae, California
TG Therapeutics Investigational Trial Site
Pismo Beach, California
TG Therapeutics Investigational Trial Site
Pleasanton, California
TG Therapeutics Investigational Trial Site
San Diego, California
TG Therapeutics Investigational Trial Site
Santa Barbara, California
TG Therapeutics Investigational Trial Site
Whittier, California
TG Therapeutics Investigational Trial Site
Aurora, Colorado
TG Therapeutics Investigational Trial Site
Denver, Colorado
TG Therapeutics Investigational Trial Site
Bridgeport, Connecticut
TG Therapeutics Investigational Trial Site
New Haven, Connecticut
TG Therapeutics Investigational Trial Site
Stamford, Connecticut
TG Therapeutics Investigational Trial Site
Newark, Delaware
TG Therapeutics Investigational Trial Site
Boca Raton, Florida
TG Therapeutics Investigational Trial Site
Fort Myers, Florida
TG Therapeutics Investigational Trial Site
Jacksonville, Florida
TG Therapeutics Investigational Trial Site
Jacksonville, Florida
TG Therapeutics Investigational Trial Site
Ocala, Florida
TG Therapeutics Investigational Trial Site
Pensacola, Florida
TG Therapeutics Investigational Trial Site
St. Petersburg, Florida
TG Therapeutics Investigational Trial Site
Tallahassee, Florida
TG Therapeutics Investigational Trial Site
Tampa, Florida
TG Therapeutics Investigational Trial Site
West Palm Beach, Florida
TG Therapeutics Investigational Trial Site
Albany, Georgia
TG Therapeutics Investigational Trial Site
Macon, Georgia
TG Therapeutics Investigational Trial Site
Chicago, Illinois
TG Therapeutics Investigational Trial Site
Decatur, Illinois
TG Therapeutics Investigational Trial Site
Maywood, Illinois
TG Therapeutics Investigational Trial Site
Niles, Illinois
TG Therapeutics Investigational Trial Site
Peoria, Illinois
TG Therapeutics Investigational Trial Site
Swansea, Illinois
TG Therapeutics Investigational Trial Site
Urbana, Illinois
TG Therapeutics Investigational Trial Site
Fort Wayne, Indiana
Showing 40 of 154 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.